Key result
Proposed clinical decision support for CKD-MBD dosing achieves ~78% concordance with routine clinical practice.
Why the study?
Clinical decision support systems have rarely focused on medication selection and dosing selection, particularly for managing chronic kidney disease-mineral and bone disorder in end-stage renal disease patients on maintenance hemodialysis.
Does a clinical decision support system provide medication dosing recommendations concordant with routine clinical practice for patients with end-stage renal disease and CKD-MBD?
Does a clinical decision support system provide medication dosing recommendations concordant with routine clinical practice for patients with end-stage renal disease and CKD-MBD?
A proposed clinical decision support system for CKD-MBD treatment in hemodialysis patients demonstrated high concordance (78.27%) with routine clinical practice and favorable usability scores.
Answers are grounded in this paper and cite their sources.
May support dosing standardization in ESRD; leaves open whether CDSS improves outcomes versus routine care.
Clinical decision support systems (CDSSs) represent the latest technological transformation in healthcare for assisting clinicians in complex decision-making. Several CDSSs are proposed to deal with a range of clinical tasks such as disease diagnosis, prescription management, and medication ordering. Although a small number of CDSSs have focused on treatment selection, areas such as medication selection and dosing selection remained under-researched. In this regard, this study represents one of the first studies in which a CDSS is proposed for clinicians who manage patients with end-stage renal disease undergoing maintenance hemodialysis, almost all of whom have some manifestation of chronic kidney disease-mineral and bone disorder (CKD-MBD). The primary objective of the system is to aid clinicians in dosage prescription by levering medical domain knowledge as well existing practices. The proposed CDSS is evaluated with a real-world hemodialysis patient dataset acquired from Kyung Hee University Hospital, South Korea. Our evaluation demonstrates overall high compliance based on the concordance metric between the proposed CKD-MBD CDSS recommendations and the routine clinical practice. The concordance rate of overall medication dosing selection is 78.27%. Furthermore, the usability aspects of the system are also evaluated through the User Experience Questionnaire method to highlight the appealing aspects of the system for clinicians. The overall user experience dimension scores for pragmatic, hedonic, and attractiveness are 1.53, 1.48, and 1.41, respectively. A service reliability for the Cronbach's alpha coefficient greater than 0.7 is achieved using the proposed system, whereas a dependability coefficient of the value 0.84 reveals a significant effect.
No takes yet. Share an insight, caveat, or question.
Ali et al. (2021) studied Chronic kidney disease-mineral and bone disorder (CKD-MBD). Clinical Decision Support System (CDSS) vs. Routine clinical practice was evaluated on Concordance rate of overall medication dosing selection. A proposed clinical decision support system for CKD-MBD medication dosing achieved a 78.27% concordance rate with routine clinical practice.
Synapse has enriched 10 related papers. Consider them for comparative context: